Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
應用
A potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand). It inhibits proliferation of mesothelioma cells by selective down-regulation of fibroblast growth factor receptors. Furthermore, it has been shown to enhance the anti-tumor effect of dendritic cell vaccines.
參考文獻
Weber, T. et al.: Clin. Can Res., 8, 863 (2002);Staphelberg, M. et al.: Biochem. Biophys. Res. Comm., 318, 636 (2004); Ramathapuram, L.V. et al.: Cancer Immunol. Immununother., 55, 166 (2005);
滬ICP備17019645號
400-821-0725
